Johns Hopkins School Of Medicine Among Clinical Trial Sites Testing COVID-19 Therapies

Johns Hopkins School of Medicine is one of more than 50 clinical trial sites across the country testing potential therapies for COVID-19 outpatients with mild to moderate symptoms. The program is part of Operation Warp Speed. “I think we’re really going to get to a place where we have this is a treatable disease as opposed to an untreatable disease,” Dr. Kelly Dooley, of Johns Hopkins School of Medicine, said. (WJZ)

Read Full Article